Article PDF
Avoid common mistakes on your manuscript.
References
Hyun, T.S., and Ross, T.S. (2004). HIP1: trafficking roles and regulation of tumorigenesis. Trends Mol Med 10, 194–199.
Kladney, R.D., Bulla, G.A., Guo, L., Mason, A.L., Tollefson, A.E., Simon, D.J., Koutoubi, Z., and Fimmel, C.J. (2000). GP73, a novel Golgi-localized protein upregulated by viral infection. Gene 249, 53–65.
Marrero, J.A., Romano, P.R., Nikolaeva, O., Steel, L., Mehta, A., Fimmel, C.J., Comunale, M.A., D’Amelio, A., Lok, A.S., and Block, T.M. (2005). GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol 43, 1007–1012.
Mosesson, Y., Mills, G.B., and Yarden, Y. (2008). Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer 8, 835–850.
Parachoniak, C.A., Luo, Y., Abella, J.V., Keen, J.H., and Park, M. (2011). GGA3 functions as a switch to promote met receptor recycling, essential for sustained ERK and cell migration. Dev Cell 20, 751–763.
Puri, S., Bachert, C., Fimmel, C.J., and Linstedt, A.D. (2002). Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption. Traffic 3, 641–653.
Scott, K.L., Kabbarah, O., Liang, M.C., Ivanova, E., Anagnostou, V., Wu, J., Dhakal, S., Wu, M., Chen, S., Feinberg, T., Huang, J., Saci, A., Widlund, H.R., Fisher, D.E., Xiao, Y., Rimm, D.L., Protopopov, A., Wong, K.K., and Chin, L. (2009). GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature 459, 1085–1090.
Sorkin, A., and von Zastrow, M. (2009). Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol 10, 609–622.
Wlodkowic, D., Skommer, J., McGuinness, D., Hillier, C., and Darzynkiewicz, Z. (2009). ER-Golgi network—A future target for anti-cancer therapy. Leukemia Res 33, 1440–1447.
Ye, Q.H., Zhu, W.W., Zhang, J.B., Qin, Y., Lu, M., Lin, G.L., Guo, L., Zhang, B., Lin, Z.H., Roessler, S., Forgues, M., Jia, H.L., Lu, L., Zhang, X.F., Lian, B.F., Xie, L., Dong, Q.Z., Tang, Z.Y., Wang, X.W., and Qin, L.X. (2016). GOLM1 modulates EGFR/RTK cell-surface recycling to drive hepatocellular carcinoma metastasis. Cancer Cell 30, 444–458.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (81472677).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Zhu, W., Qin, L. GOLM1-regulated EGFR/RTK recycling is a novel target for combating HCC metastasis. Sci. China Life Sci. 60, 98–101 (2017). https://doi.org/10.1007/s11427-016-0311-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-016-0311-x